GlassScriptPhysician profile
Rajesh K Sheth
NPI 1194734152
$3,981.85
in general payments reported to CMS, 2019-2025
21 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,452 · 2020: $851 · 2021: $282 · 2022: $759 · 2023: $136 · 2024: $207 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $730.34 | 2019-2020 | |
| Pfizer INC. | $431.49 | 2019-2020 | |
| Genzyme Corporation | $357.74 | 2022-2025 | |
| Glaxosmithkline, LLC. | $278.14 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $250.00 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $233.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $219.66 | 2019-2020 | |
| Penumbra, INC. | $177.00 | 2021 | |
| Gt Medical Technologies, INC | $171.96 | 2025 | Gammatile |
| Boston Scientific Corporation | $142.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.64 | 2019 | |
| Esperion Therapeutics, INC. | $122.15 | 2022 | |
| Sirtex Medical INC | $114.99 | 2022 | |
| Amgen INC. | $114.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $111.17 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $104.63 | 2021 | |
| Medtronic, INC. | $82.20 | 2024 | Azure Xt Dr Mri Surescan |
| Sunovion Pharmaceuticals INC. | $81.12 | 2019-2020 | |
| Daiichi Sankyo INC. | $65.99 | 2022 | |
| Avanir Pharmaceuticals, INC. | $41.34 | 2019-2020 | |
| Indivior INC. | $26.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.